Insurance, Pharmaceutical Services
"Insurance, Pharmaceutical Services" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insurance providing for payment of services rendered by the pharmacist. Services include the preparation and distribution of medical products.
| Descriptor ID |
D007356
|
| MeSH Number(s) |
N03.219.521.576.343.575
|
| Concept/Terms |
Insurance, Pharmaceutical Services- Insurance, Pharmaceutical Services
- Pharmacy Services Insurance
- Pharmaceutic Services Insurance
- Pharmaceutical Services Insurance
- Insurance, Pharmaceutic Services
- Insurance, Pharmacy Services
Drug Benefit Plans- Drug Benefit Plans
- Drug Benefit Plan
- Plan, Drug Benefit
- Plans, Drug Benefit
|
Below are MeSH descriptors whose meaning is more general than "Insurance, Pharmaceutical Services".
Below are MeSH descriptors whose meaning is more specific than "Insurance, Pharmaceutical Services".
This graph shows the total number of publications written about "Insurance, Pharmaceutical Services" by people in this website by year, and whether "Insurance, Pharmaceutical Services" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2005 | 6 | 0 | 6 |
| 2006 | 3 | 0 | 3 |
| 2010 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2019 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insurance, Pharmaceutical Services" by people in Profiles.
-
Lazar A, Rappaport DI, Sharif I, Hossain MJ. Factors Associated With Pickup of Pediatric Discharge Prescriptions. Hosp Pediatr. 2019 06; 9(6):440-446.
-
Hess GP, Natarajan P, Faridi KF, Fievitz A, Valsdottir L, Yeh RW. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Therapy: Payer Approvals and Rejections, and Patient Characteristics for Successful Prescribing. Circulation. 2017 Dec 05; 136(23):2210-2219.
-
Lam NN, Schnitzler MA, Segev DL, Hess GP, Kasiske BL, Randall HB, Axelrod D, Xiao H, Garg AX, Brennan DC, Lentine KL. Diabetes Mellitus in Living Pancreas Donors: Use of Integrated National Registry and Pharmacy Claims Data to Characterize Donation-Related Health Outcomes. Transplantation. 2017 06; 101(6):1276-1281.
-
Shaffer ER, Sarfaty M, Ash AS. Contraceptive insurance mandates. Med Care. 2012 Jul; 50(7):559-61.
-
Abouzaid S, Jutkowitz E, Foley KA, Pizzi LT, Kim E, Bates J. Economic impact of prior authorization policies for atypical antipsychotics in the treatment of schizophrenia. Popul Health Manag. 2010 Oct; 13(5):247-54.
-
Stefanacci R. Senior enrollment in Medicare Part D. Manag Care. 2006 Jul; 15(7 Suppl 3):9-13.
-
Stefanacci RG. Medicare Part D: where we are and where we're going. Manag Care. 2006 Jul; 15(7 Suppl 3):2-5.
-
Stefanacci RG. Are you health-insurance literate? A question for physicians. J Am Geriatr Soc. 2006 Jan; 54(1):166-8.
-
Stefanacci RG. The cost of being excluded: impact of excluded medications under Medicare part D on nursing home residents. J Am Med Dir Assoc. 2005 Nov-Dec; 6(6):415-20.
-
Bielory L. United States pharmacopeia development of the Medicare model formulary guidelines. Am J Geriatr Cardiol. 2005 Nov-Dec; 14(6):301-7.